CN110214955B - Composition with function of nourishing ovaries and preparation method thereof - Google Patents
Composition with function of nourishing ovaries and preparation method thereof Download PDFInfo
- Publication number
- CN110214955B CN110214955B CN201910607377.6A CN201910607377A CN110214955B CN 110214955 B CN110214955 B CN 110214955B CN 201910607377 A CN201910607377 A CN 201910607377A CN 110214955 B CN110214955 B CN 110214955B
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- ovaries
- nourishing
- function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001672 ovary Anatomy 0.000 title claims abstract description 51
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 40
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 34
- 108010084695 Pea Proteins Proteins 0.000 claims abstract description 31
- 235000019702 pea protein Nutrition 0.000 claims abstract description 31
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 30
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 21
- 235000021279 black bean Nutrition 0.000 claims abstract description 21
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 20
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 20
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 20
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 20
- 235000019152 folic acid Nutrition 0.000 claims abstract description 20
- 229960000304 folic acid Drugs 0.000 claims abstract description 20
- 239000011724 folic acid Substances 0.000 claims abstract description 20
- 235000012661 lycopene Nutrition 0.000 claims abstract description 20
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 20
- 239000001751 lycopene Substances 0.000 claims abstract description 20
- 229960004999 lycopene Drugs 0.000 claims abstract description 20
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 20
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 20
- 239000011710 vitamin D Substances 0.000 claims abstract description 20
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 20
- 229940046008 vitamin d Drugs 0.000 claims abstract description 20
- 229930189775 mogroside Natural products 0.000 claims abstract description 17
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 16
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 16
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 16
- 235000004347 Perilla Nutrition 0.000 claims abstract description 16
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 16
- 241000756042 Polygonatum Species 0.000 claims abstract description 15
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 15
- 244000124853 Perilla frutescens Species 0.000 claims abstract 3
- 230000002611 ovarian Effects 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract description 8
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract description 8
- 229940028334 follicle stimulating hormone Drugs 0.000 abstract description 8
- 230000032683 aging Effects 0.000 abstract description 6
- 230000007423 decrease Effects 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 23
- 230000006870 function Effects 0.000 description 23
- 241000229722 Perilla <angiosperm> Species 0.000 description 13
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 10
- 206010036601 premature menopause Diseases 0.000 description 10
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 10
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 8
- 229940011871 estrogen Drugs 0.000 description 8
- 239000000262 estrogen Substances 0.000 description 8
- 229940088597 hormone Drugs 0.000 description 8
- 239000005556 hormone Substances 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 4
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 4
- 235000008696 isoflavones Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229940001941 soy protein Drugs 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000003325 follicular Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000000287 oocyte Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000002657 hormone replacement therapy Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 201000004535 ovarian dysfunction Diseases 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000906543 Actaea racemosa Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 241000893536 Epimedium Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
- 206010033165 Ovarian failure Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 241001633680 Polygonatum odoratum Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003429 anti-cardiolipin effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 1
- 230000002060 circadian Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000004970 emotional disturbance Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940094892 gonadotropins Drugs 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015124 ovarian disease Diseases 0.000 description 1
- 231100000543 ovarian dysfunction Toxicity 0.000 description 1
- 231100000539 ovarian failure Toxicity 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a composition with an ovary nourishing function and a preparation method thereof, wherein the composition comprises 30-50 parts of soybean protein, 15-25 parts of pea protein, 15-25 parts of black beans, 3-6 parts of kudzuvine roots, 1-5 parts of perilla, 1-5 parts of medlar, 3-6 parts of polygonatum, 0.1-0.8 part of lycopene, 0.1-0.5 part of folic acid, 0.1-0.5 part of vitamin D and 0.01-0.05 part of mogroside. The composition can slow down the aging of the ovaries, control the follicle stimulating hormone within a normal range, improve the reserve function of the ovaries, particularly prevent the decline of the reserve function of the ovaries in early stage, inhibit or delay the decline of the reserve function of the ovaries, and play a good role in nourishing the ovaries.
Description
Technical Field
The invention belongs to the field of health foods, and particularly relates to a composition with an ovarian nourishing function and a preparation method thereof.
Background
The ovaries are positioned in the female pelvis, are paired parenchymal organs, and are important manifestations of female intrinsic beauty. The ovary is well maintained, so that the facial skin is fine and smooth, white and transparent, the toughness and elasticity are kept permanently, and the reproduction and the body health are promoted. Ovaries play a very important role in the life of females. The health of the ovaries can greatly affect the health of females.
Premature ovarian failure, decreased reserve function, and the like are common symptoms of ovarian failure. The reserve function of the ovaries refers to the ability of the ovaries to grow, develop and form fertilizable oocytes, including the number and quality of the follicles, in the cortex area of the ovaries, which also reflects the reproductive potential and reproductive endocrine function of females. Premature ovarian failure is a gynecological endocrine disease that results from premature ovarian failure due to multiple factors, and is generally defined as amenorrhea, infertility, hypoestrogenism, elevated gonadotrophin levels, etc. in females before age 40 due to ovarian and follicular depletion.
The traditional Chinese medicine considers that kidney yin deficiency, loss of the daily and the decyl, and damage of the two vessels of the thoroughfare and conception vessel are the main pathological mechanisms of premature ovarian failure. There are also many studies on improving premature ovarian failure by using traditional Chinese medicines, for example, researches show that epimedium has remarkable curative effects on premature ovarian failure and the like, and other traditional Chinese medicines for tonifying kidney and strengthening spleen also have good curative effects on premature ovarian failure.
For the complicated cause of the onset of ovarian-related diseases, common factors include the following: emotional disturbances, depression anxiety, and the like can affect the secretion of central neurotransmitters and thus interfere with the central nervous system, and mental stimulation re-creation can cause abnormal gene expression of related substances that mediate the balance function of the neuroendocrine immune network system. Ovarian autoimmune antibodies such as anti-ovarian antibodies, anti-zona pellucida antibodies, anti-cardiolipin antibodies, and the like, result in a reduction in ovarian volume and a reduction in the number of follicles. With age symptoms, the accumulation of free radicals and active oxygen in the egg cytoplasm, mitochondrial mutation increase, meiosis abnormality, reduced number of oocytes, reduced quality, follicular occlusion, reduced proliferation rate of granulosa cells and increased apoptosis rate. Liu Shan et al consider age as the most important factor affecting ovarian function. It has been found that the follicular density over 30 years of age is only common under 30 years of age, and is almost 0 after 45 years of age, with increasing age, the rate of ovarian aging increases. In addition, the life rhythm, the competition and the like in the modern society also influence the reservation function of the ovary.
Up to now, there is no clearly effective therapeutic measure to restore or protect ovarian function. Currently, the main method for treating premature ovarian failure is through hormone therapy, and patients often need a small amount of estrogen, or estrogen-progestin cycle therapy. Although this method can superficially eliminate climacteric syndrome, most people are easy to relapse after stopping the drug, and the side effects of hormone also bring great burden to the body and mind of the patient. Recent clinical studies by the american society of health have found that Hormone Replacement Therapy (HRT), while reducing the risk of osteoporosis and bone fracture, increases the incidence of breast cancer, endometrial cancer, and cardiovascular and stroke. It follows that hormone replacement therapy cannot be said to be a safe and effective treatment.
The traditional Chinese medicine composition has the advantages that the traditional Chinese medicine composition is provided for 'early disease prevention, namely disease prevention and change prevention', a large amount of research data show that the traditional Chinese medicine composition with the medicinal and edible functions of nourishing yin and tonifying kidney, enriching blood, tonifying yang, soothing liver, strengthening spleen and harmonizing stomach can effectively protect and improve premature ovarian failure of females, improve hypoovarianism of the ovaries, and the like. For example Cai Lianxiang, the self-retaining ovum An Kunshang can be matched with the external application formula to treat infertility patients caused by low ovarian reserve function, and has better clinical curative effect. Although not hormone, the traditional Chinese medicine has obvious mobilization capability, especially improves the response of ovaries to gonadotropins, restores and improves the ovarian function and has obvious long-acting property.
Disclosure of Invention
Based on the problems in the prior art, the invention provides a composition for nourishing ovaries and a preparation method thereof. The invention selects the diet therapy mode, and avoids the defects caused by excessive feeding of traditional Chinese medicines.
The invention aims to conventionally nourish the ovaries or improve the functions of the ovaries, further realize the effects of regulating balance of female endocrine, delaying aging and the like, and the technical scheme of the invention is as follows.
It is an object of the present invention to provide a composition for nourishing the ovaries comprising a vegetable protein, preferably a combination of soy protein and pea protein.
Another object of the invention consists in the use of a composition comprising soy protein and pea protein for the preparation of a nourishing ovarian product.
For nourishing and/or maintaining the ovary, it is important to regulate hormone level, supplement nutrition to regulate human metabolism, remove free radicals, improve immunity, etc., for example, in the prior art, the compatibility of collagen, black cohosh, chinese angelica, trace elements and vitamins is studied to realize the maintenance of the ovary.
The soybean protein is a high-quality plant protein with nutrient components which can be compared with animal proteins such as milk, and the like, contains amino acids necessary for human bodies, has relatively balanced and reasonable components and proportion, is closest to the proportion required by human bodies in plant foods, is rich in mineral substances and vitamins, and has high digestibility. Meanwhile, the soybean protein contains phytoestrogen-soybean isoflavone with very good biological activity, and the soybean isoflavone has very outstanding effects of regulating estrogen, preventing osteoporosis and the like. The current research shows that the soybean protein has good effects of reducing serum cholesterol level, preventing atherosclerosis, preventing and treating cardiovascular diseases, osteoporosis and the like.
The pea protein contains higher mineral elements and vitamins, the amino acid ratio is balanced, the product solubility and stability are better, the pea protein can be used as a protein source of an infant formula, can reduce cholesterol and fat intake, can promote the growth of probiotics in intestinal tracts to a certain extent, and has outstanding physiological activity.
The soybean protein and the pea protein are widely applied in the field of health foods, and contain a certain amount of estrogen, and have rich amino acid, mineral substances and the like. The applicant found in the study that the compatibility of the two has good effect on nourishing the ovary.
A composition with ovary nourishing effect comprises soybean protein and pea protein 30-60 parts and 15-25 parts.
However, in the case of soy protein and pea protein, although efficacy in nourishing the ovaries was found, the content of nutrients such as estrogen was not very high. Therefore, based on further increasing the efficacy of nourishing the ovaries, it is further preferred that, in order to further increase the effect of nourishing the ovaries, the composition of the present invention further comprises the following raw materials: black beans, kudzuvine root, purple perilla, medlar, fragrant solomonseal rhizome, lycopene, folic acid, vitamin D and momordica grosvenori sweet glycoside. Wherein lycopene, folic acid, vitamin D and mogroside are all powder materials conventional in the art.
For black beans, the black beans have the highest content compared with other beans containing phytoestrogens. The black beans are rich in anthocyanin, and isoflavone in the black beans can regulate secretion of female hormone, so that the black beans have positive effects in preventing premature ovarian failure. The main ingredients of radix Puerariae include puerarin, isoflavone, etc., and have effects of inducing and promoting female hormone secretion. Therefore, as a preferable scheme of the invention, black beans and kudzuvine roots are further added to increase secretion or induction of female hormones, so that the nutrition-supplementing agent has a good effect on nourishing ovaries.
Furthermore, on the basis of adding black beans and kudzuvine roots, the polygonatum is further added, so that the polygonatum has the effects of improving ovarian response, increasing sensitivity, nourishing yin, moisturizing lung, nourishing qi and replenishing blood, and can further promote secretion of female hormone, thereby achieving the purpose of nourishing ovaries.
Further, as described in the present invention, the integrity of the nutrients is also important when the ovaries are nourished, so that the present invention further adds the perilla and the medlar to improve the health care effect of the whole composition, the perilla can improve the immunity, the medlar has the effects of replenishing essence, resisting aging, etc., and the addition of the above components makes the whole composition have remarkable effect of nourishing the ovaries in the present invention.
The efficacy of the substances is well known to researchers in the field, and lycopene has strong antioxidant capacity, can effectively protect the structure and function of egg cells, folic acid can promote the maturation of oocytes, and vitamin D has outstanding effect of preventing polycystic ovary syndrome.
Therefore, as a preferable scheme, the composition for nourishing the ovary also comprises black beans, kudzuvine roots, perilla, medlar, polygonatum, lycopene, folic acid, vitamin D and mogroside. Namely, the addition of the raw materials and the combined action of the soybean protein and the pea protein have obvious synergistic effect.
Further, the composition of the present invention comprises the following components: 30-50 parts of soybean protein, 15-25 parts of pea protein, 15-25 parts of black beans, 3-6 parts of kudzuvine root, 1-5 parts of perilla, 1-5 parts of medlar, 3-6 parts of fragrant solomonseal rhizome, 0.1-0.8 part of lycopene, 0.1-0.5 part of folic acid, 0.1-0.5 part of vitamin D and 0.01-0.05 part of mogroside.
Further, the raw materials comprise 35-45 parts of soybean protein, 17-25 parts of pea protein, 20-25 parts of black beans, 3-5 parts of kudzuvine roots, 2-4 parts of perilla, 2-4 parts of medlar, 3-5 parts of fragrant solomonseal rhizome, 0.1-0.5 part of lycopene, 0.1-0.3 part of folic acid, 0.1-0.3 part of vitamin D and 0.01-0.03 part of mogroside.
The technical scheme of the invention also comprises the application of the composition of the soybean protein and the pea protein in preparing the ovary nourishing product, wherein the usage amount of the soybean protein and the pea protein is 30-50 parts and 15-25 parts.
Further, for the purposes, the composition comprising soybean protein and pea protein further comprises 15-25 parts of black beans, 3-6 parts of kudzuvine roots, 1-5 parts of perilla, 1-5 parts of medlar, 3-6 parts of polygonatum, 0.1-0.8 part of lycopene, 0.1-0.5 part of folic acid, 0.1-0.5 part of vitamin D and 0.01-0.05 part of mogroside.
The preparation method of the composition comprises the following steps:
(1) Weighing semen Sojae Atricolor, radix Puerariae, perillae herba, fructus Lycii and rhizoma Polygonati Odorati at a certain proportion, adding 10-15 times of water, heating and extracting for 2 times for 1-3 hr, and concentrating to obtain extract;
(2) Mixing lycopene, folic acid, vitamin D and mogroside uniformly, and sieving with 100 mesh sieve;
(3) Spray-drying the extract obtained in the step (1) and the mixture obtained in the step (2) together to obtain spray-dried powder;
(4) Mixing the spray-dried powder with soybean protein and pea protein uniformly by a three-dimensional mixer.
The composition of the invention can be prepared into dosage forms including solid beverage, electuary, tablet, granule, powder, paste and the like, and auxiliary materials common in the field can be added to obtain the dosage forms.
Further, the water added in the step (1) is 10 times of the water added in the raw materials, the extraction time is 2 hours, and the mixing time in the step (4) is 15-40 minutes.
The beneficial effects of the invention include: the ovarian aging is slowed down, the follicle-stimulating hormone is controlled in a normal range, the reserve function of the ovary is improved, and particularly in the aspect of prevention, the ovarian aging can be inhibited or delayed in early stage, and the ovarian nourishing effect is achieved. The combination of the soybean protein and the pea protein has obvious interaction promotion effect when being used for curing the ovary; is compatible with black beans, kudzuvine roots, purple perilla, medlar, fragrant solomonseal rhizome, lycopene, folic acid and vitamin D, adjusts hormone level, and has more positive effect on nourishing ovaries (including ovarian dysfunction diseases and the like).
Detailed Description
Example 1
A composition with ovary nourishing function comprises soybean protein and pea protein, and the dosage of the soybean protein and pea protein is 40:15.
Example 2
The composition with the function of nourishing the ovaries is prepared from the following raw materials: 45 parts of soybean protein, 20 parts of pea protein, 20 parts of black beans, 3 parts of kudzuvine root, 2 parts of perilla, 2 parts of medlar, 3 parts of fragrant solomonseal rhizome, 0.1 part of lycopene, 0.1 part of folic acid, 0.1 part of vitamin D and 0.01 part of mogroside.
Example 3
The composition with the function of nourishing the ovaries is prepared and processed by the following method: (1) Weighing semen Sojae Atricolor, radix Puerariae, perillae herba, fructus Lycii, and rhizoma Polygonati Odorati according to the ratio (described in example 2), adding 10 times of water, heating and extracting for 2 times, each time for 2 hr, and concentrating to obtain extract;
(2) Mixing lycopene, folic acid, vitamin D and mogroside uniformly, and sieving with 100 mesh sieve;
(3) Spray-drying the extract obtained in the step (1) and the mixture obtained in the step (2) together to obtain spray-dried powder;
(4) Mixing the spray-dried powder with soybean protein and pea protein uniformly by a three-dimensional mixer.
Example 4
The composition with the function of nourishing the ovaries is prepared from the following raw materials: 40 parts of soybean protein, 20 parts of pea protein, 20 parts of black beans, 3.5 parts of kudzuvine root, 2.5 parts of perilla, 2 parts of medlar, 3 parts of fragrant solomonseal rhizome, 0.15 part of lycopene, 0.15 part of folic acid, 0.1 part of vitamin D and 0.01 part of mogroside.
Comparative example 1
Composition with ovary nourishing function comprises soybean protein and pea protein, wherein the dosage of the soybean protein and the pea protein is 6:1.
Comparative example 2
A composition with ovary nourishing function comprises soybean protein and collagen, and the dosage of the soybean protein and collagen is 40:15.
Comparative example 3
The composition with the function of nourishing the ovaries is prepared from the following raw materials: 45 parts of soybean protein, 20 parts of pea protein, 2 parts of purple perilla, 2 parts of medlar, 3 parts of polygonatum odoratum, 0.1 part of lycopene, 0.1 part of folic acid, 0.1 part of vitamin D and 0.01 part of mogroside.
Comparative example 4
The composition with the function of nourishing the ovaries is prepared from the following raw materials: 45 parts of soybean protein, 20 parts of pea protein, 20 parts of black beans, 3 parts of radix puerariae, 0.1 part of lycopene, 0.1 part of folic acid, 0.1 part of vitamin D and 0.01 part of mogroside.
Comparative example 5
The composition with the function of nourishing the ovaries is prepared from the following raw materials: 45 parts of soybean protein, 20 parts of pea protein, 20 parts of black beans, 3 parts of kudzuvine root, 2 parts of perilla, 2 parts of medlar, 3 parts of fragrant solomonseal rhizome and 0.01 part of mogroside.
Effect experiment
Healthy female Kunming mice are selected as study subjects, the mice are 8 weeks old, the raising temperature is 22-25 ℃, the relative humidity is 50-65%, the mice are irradiated for 12 hours every day, the mice are adaptively raised according to normal circadian physiological laws, and the mice drink and eat freely, and each group of mice contains 12 mice. After the adaptive feeding is finished, the experiment is carried out, the dose of the experiment is set according to the weight ratio of human body to mice, the experiment time is set to 7 days, and the empty group is filled with distilled water with the same amount.
The measuring method comprises the following steps: serum estradiol (E2) and Follicle Stimulating Hormone (FSH) levels were measured by the Elisa method, and specific methods were performed with reference to prior art measurement methods, such as a double antibody two-step sandwich enzyme-linked immunosorbent assay (Elisa) for the E2 index. And adding the standard substance and the sample to be tested into a transparent enzyme-labeled coating plate of the pre-coated mouse estrogen monoclonal antibody, after incubating for a sufficient time, washing to remove unbound parts, adding enzyme-labeled working solution, and after incubating for a sufficient time, washing to remove unbound parts. Sequentially adding the substrates A and B, converting the substrates into blue products under the catalysis of horseradish peroxidase, changing the substrates into yellow under the action of acid, positively correlating the color shade with the estrogen concentration of the rat and the mouse in the sample, measuring the OD value at the wavelength of 450nm, and calculating the content of E2 according to the OD values of the sample and the standard. Likewise, FSH is also determined based on conventional assay methods in the prior art.
That is, as can be seen from the table, example 1 and example 3 were significantly superior to the blank group, and the difference was significant. Meanwhile, the content of estrogen is obviously higher in the example 3 compared with the control group, which shows that the composition of the invention has more obvious effect of improving estrogen secretion. Likewise, the results of example 3 are also significantly better than the control for FSH index (high follicle stimulating hormone is likely to cause endocrine dysfunction).
From the results, the composition has obvious effects of nourishing ovaries (two important indexes: E2 and FSH), and the mutual compatibility effect of soy protein, pea protein, black beans, kudzuvine roots, perilla, medlar, fragrant solomonseal rhizome, lycopene, folic acid and vitamin D is more obvious.
It is to be understood that the above examples of the present invention are provided by way of illustration only and not by way of limitation of the embodiments of the present invention. Other variations or modifications of the above teachings will be apparent to those of ordinary skill in the art. It is not necessary here nor is it exhaustive of all embodiments. Any modification, equivalent replacement, improvement, etc. which come within the spirit and principles of the invention are desired to be protected by the following claims.
Claims (5)
1. A composition with the function of nourishing ovaries, which is characterized by being prepared from the following components: 30-50 parts of soybean protein, 15-25 parts of pea protein, 15-25 parts of black beans, 3-6 parts of kudzuvine roots, 1-5 parts of perilla, 1-5 parts of medlar, 3-6 parts of polygonatum, 0.1-0.8 part of lycopene, 0.1-0.5 part of folic acid, 0.1-0.5 part of vitamin D and 0.01-0.05 part of mogroside;
the preparation method comprises the following steps:
(1) Weighing semen Sojae Atricolor, radix Puerariae, perillae herba, fructus Lycii and rhizoma Polygonati Odorati at a certain proportion, adding 10-15 times of water, heating and extracting for 2 times for 1-3 hr, and concentrating to obtain extract;
(2) Mixing lycopene, folic acid, vitamin D and mogroside uniformly, and sieving with 100 mesh sieve to obtain a mixture;
(3) Spray-drying the extract obtained in the step (1) and the mixture obtained in the step (2) together to obtain spray-dried powder;
(4) Mixing the spray-dried powder with soybean protein and pea protein uniformly by a three-dimensional mixer.
2. The composition with the function of nourishing ovaries according to claim 1, wherein the amounts of the components are 35-45 parts of soybean protein, 17-25 parts of pea protein, 20-25 parts of black beans, 3-5 parts of kudzuvine roots, 2-4 parts of perilla, 2-4 parts of medlar, 3-5 parts of polygonatum, 0.1-0.5 part of lycopene, 0.1-0.3 part of folic acid, 0.1-0.3 part of vitamin D and 0.01-0.03 part of mogroside.
3. A method of preparing a composition having a tonic ovarian function as claimed in claim 1, comprising the steps of:
(1) Weighing semen Sojae Atricolor, radix Puerariae, perillae herba, fructus Lycii and rhizoma Polygonati Odorati at a certain proportion, adding 10-15 times of water, heating and extracting for 2 times for 1-3 hr, and concentrating to obtain extract;
(2) Mixing lycopene, folic acid, vitamin D and mogroside uniformly, and sieving with 100 mesh sieve to obtain a mixture;
(3) Spray-drying the extract obtained in the step (1) and the mixture obtained in the step (2) together to obtain spray-dried powder;
(4) Mixing the spray-dried powder with soybean protein and pea protein uniformly by a three-dimensional mixer.
4. The composition with the function of nourishing ovaries according to claim 1, wherein the preparation formulation of the composition comprises solid beverage, electuary, tablet, granule, powder and ointment.
5. The method for preparing a composition with ovarian nourishing function according to claim 3, wherein the amount of water added in the step (1) is 10 times that of the raw material, the extraction time is 2 hours, and the mixing time in the step (4) is 15-40 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910607377.6A CN110214955B (en) | 2019-07-07 | 2019-07-07 | Composition with function of nourishing ovaries and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910607377.6A CN110214955B (en) | 2019-07-07 | 2019-07-07 | Composition with function of nourishing ovaries and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110214955A CN110214955A (en) | 2019-09-10 |
| CN110214955B true CN110214955B (en) | 2024-02-02 |
Family
ID=67812721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910607377.6A Active CN110214955B (en) | 2019-07-07 | 2019-07-07 | Composition with function of nourishing ovaries and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110214955B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113693023B (en) * | 2021-09-03 | 2022-09-02 | 河南省农业科学院畜牧兽医研究所 | Processing method for improving group entering efficiency of replacement gilts with no estrus in excess period |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181069A (en) * | 2007-11-30 | 2008-05-21 | 天津科技大学 | Complex nutrition albumen powder for preventing women's osteosporosis after menopause |
| CN106852498A (en) * | 2015-12-09 | 2017-06-16 | 池州千年坊生物科技有限公司 | A kind of sealwort albumen powder and preparation method thereof |
| CN107348379A (en) * | 2017-07-05 | 2017-11-17 | 上海拜汶医药科技有限公司 | A kind of composite nutrient protected and improve women ovarian function |
| CN109363187A (en) * | 2018-09-14 | 2019-02-22 | 黑龙江飞鹤乳业有限公司 | It is a kind of to adjust immune, antifatigue and relax bowel and defecation composition and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170196924A1 (en) * | 2015-12-15 | 2017-07-13 | All Natural Protectors, LLC | Composition for supporting cellular structure and adhesion |
-
2019
- 2019-07-07 CN CN201910607377.6A patent/CN110214955B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181069A (en) * | 2007-11-30 | 2008-05-21 | 天津科技大学 | Complex nutrition albumen powder for preventing women's osteosporosis after menopause |
| CN106852498A (en) * | 2015-12-09 | 2017-06-16 | 池州千年坊生物科技有限公司 | A kind of sealwort albumen powder and preparation method thereof |
| CN107348379A (en) * | 2017-07-05 | 2017-11-17 | 上海拜汶医药科技有限公司 | A kind of composite nutrient protected and improve women ovarian function |
| CN109363187A (en) * | 2018-09-14 | 2019-02-22 | 黑龙江飞鹤乳业有限公司 | It is a kind of to adjust immune, antifatigue and relax bowel and defecation composition and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 海春旭主编.《自由基医学》.第四军医大学出版社,2006,第238页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110214955A (en) | 2019-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101991020B (en) | Traditional Chinese medicine chicken feed and production method of black bone chicken egg with effects of regulating internal secretion of human body and removing spots and beautifying and protecting health | |
| US7927631B2 (en) | Formulations and treatments for well-being | |
| CN106174585A (en) | Hypoglycemic compositions and hypoglycemic compound probiotic spy's dietary seafood | |
| CN103725469B (en) | A kind of health dry red winew | |
| CN105795468A (en) | Composition having efficacy of losing weight | |
| EP2481389A1 (en) | Formulations and treatments for trichology | |
| CN110179125A (en) | A kind of composition and preparation method thereof promoting Recovery | |
| CN109090617A (en) | It is a kind of to have effects that the formulation product of qi-supplementing, blood-engendering | |
| CN110214955B (en) | Composition with function of nourishing ovaries and preparation method thereof | |
| CN106578139A (en) | Rapeseed oil for invigorating brain and application of rapeseed oil | |
| CN113398078A (en) | Granular traditional Chinese medicine for improving ovarian reserve function and preparation method thereof | |
| CN110742269B (en) | Memory enhancing composition suitable for postpartum women and preparation method thereof | |
| CN107136281A (en) | It is a kind of to be used to improve kelp cordyceps sinensis pressed candy of women renal function and preparation method thereof | |
| CN110115386A (en) | A kind of alimentation composition and preparation method thereof improving ovarian function | |
| CN102441069A (en) | Prebiotic longevity tablet and its preparation method | |
| CN109744543A (en) | A kind of bone collagen peptide composite powder and preparation method thereof | |
| CN105030858A (en) | Cynomorium songaricum healthcare tablet and preparation method thereof | |
| CN101152215B (en) | Anti-senescence product for gonad granulocyte, its preparing method and uses | |
| CN108095075A (en) | Miscarriage women tailored version clinical nutrition formula and preparation method thereof | |
| CN113413419A (en) | Ovary care composition containing jujube exosome and preparation method thereof | |
| CN113648347A (en) | Ovary care composition containing lotus seed exosome and preparation method thereof | |
| CN102511882A (en) | Red jujube thick syrup beneficial for improving growth and development | |
| CN112586743A (en) | Meal replacement food and preparation method thereof | |
| CN112076292A (en) | Powder with functions of enhancing immunity and regulating kidney yin deficiency and preparation method thereof | |
| CN110495607A (en) | A kind of procyanidine oligosaccharide endocrine metabolic diseases powder and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |